A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Eikon Therapeutics
Novartis
GlaxoSmithKline
Radiopharm Theranostics, Ltd
Replimune Inc.
GlaxoSmithKline
ImmunityBio, Inc.
Massive Bio, Inc.
Medicenna Therapeutics, Inc.
Shattuck Labs, Inc.
Incyte Corporation
Molecular Templates, Inc.
Apollomics (Australia) Pty. Ltd.
Incyte Corporation